Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

H Daniel Lacorazza

Showing results (1-10 of 36) with videos related to

Pageof 4
Sort By:
Frontiers in Oncology|December 24, 2024
Pharmacological inhibition of the MAP2K7 kinase in human diseaseH Daniel Lacorazza
Frontiers in Immunology|July 1, 2025
The reprogramming factor KLF4 in normal and malignant blood cellsH Daniel Lacorazza
Current Cancer Drug Targets|May 28, 2014
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?Koramit Suppipat, H Daniel Lacorazza
Blood Cells, Molecules & Diseases|November 26, 2003
The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesisH Daniel Lacorazza, Stephen D Nimer
Methods in Molecular Biology (Clifton, N.J.)|October 15, 2017
Retroviral Transduction of Quiescent Murine Hematopoietic Stem CellsChun Shik Park, H Daniel Lacorazza
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Exclusion and inclusion of TCR alpha proteins during T cell development in TCR-transgenic and normal miceH Daniel Lacorazza, Janko Nikolich-Zugich
Experimental & Molecular Medicine|October 17, 2020
DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cellsChun Shik Park, H Daniel Lacorazza
European Journal of Immunology|December 17, 2013
Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infectionMaksim Mamonkin, Monica Puppi, H Daniel Lacorazza
Cell Cycle (Georgetown, Tex.)|July 11, 2013
Genetic control of quiescence in hematopoietic stem cellsTakeshi Yamada, Chun Shik Park, H Daniel Lacorazza
Experimental Hematology|May 9, 2017
Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemiaYe Shen, Taylor J Chen, H Daniel Lacorazza
Pageof 4

Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Frontiers in Oncology|December 24, 2024
Pharmacological inhibition of the MAP2K7 kinase in human diseaseH Daniel Lacorazza
Frontiers in Immunology|July 1, 2025
The reprogramming factor KLF4 in normal and malignant blood cellsH Daniel Lacorazza
Current Cancer Drug Targets|May 28, 2014
From the Table to the Bedside: Can Food-Derived Sulforaphane be used as a Novel Agent to Treat Leukemia?Koramit Suppipat, H Daniel Lacorazza
Blood Cells, Molecules & Diseases|November 26, 2003
The emerging role of the myeloid Elf-1 like transcription factor in hematopoiesisH Daniel Lacorazza, Stephen D Nimer
Methods in Molecular Biology (Clifton, N.J.)|October 15, 2017
Retroviral Transduction of Quiescent Murine Hematopoietic Stem CellsChun Shik Park, H Daniel Lacorazza
Journal of Immunology (Baltimore, Md. : 1950)|October 21, 2004
Exclusion and inclusion of TCR alpha proteins during T cell development in TCR-transgenic and normal miceH Daniel Lacorazza, Janko Nikolich-Zugich
Experimental & Molecular Medicine|October 17, 2020
DYRK2 controls a key regulatory network in chronic myeloid leukemia stem cellsChun Shik Park, H Daniel Lacorazza
European Journal of Immunology|December 17, 2013
Transcription factor ELF4 promotes development and function of memory CD8(+) T cells in Listeria monocytogenes infectionMaksim Mamonkin, Monica Puppi, H Daniel Lacorazza
Cell Cycle (Georgetown, Tex.)|July 11, 2013
Genetic control of quiescence in hematopoietic stem cellsTakeshi Yamada, Chun Shik Park, H Daniel Lacorazza
Experimental Hematology|May 9, 2017
Novel tumor-suppressor function of KLF4 in pediatric T-cell acute lymphoblastic leukemiaYe Shen, Taylor J Chen, H Daniel Lacorazza
Pageof 4